Related Experiment Video
Updated: Aug 10, 2026

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
Drug-induced hyperprolactinemia
1Associate Specialist in Diabetes & Endocrinology, Sandwell Medical Research Unit, Sandwell General Hospital, West Midlands, UK. prabirbanerjee@yahoo.co.uk
Abstract:
Hyperprolactinemia is the most common biochemical abnormality currently encountered in clinical endocrinology. Hyperprolactinemic syndromes are a diverse group of disorders that are common in both men and women. Once the diagnosis of hyperprolactinemia has been established, the patient should be screened for the numerous causes of hormone hypersecretion. Hence, an accurate medical history is extremely important for the clinician to find out the most frequent causes of hypersecretion of prolactin (e.g., drugs). Clinicians should be aware of the possibility of prolactin elevation and associated problems with any drug that has the potential to cause hyperprolactinemia, particularly in patients who have other factors that might stimulate prolactin release.
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Mania and Antimanic Drugs: Overview
Drug Toxicity: Dose-Dependent Reactions
Cushing Syndrome II: Pathophysiology
Desensitization and Tachyphylaxis
Several...
Cushing Syndrome I: Introduction

